NM_001304717.5:c.1411C>G LRG_311t1:c.892C>G LRG_311:g.102546C>G NG_007466.2:g.102546C>G
NC_000010.10:g.89720741C>G NP_000305.3:p.Gln298Glu NM_000314.4:c.892C>G NM_000314.6:c.892C>G NP_001291647.1:p.Gln101Glu NP_001291646.4:p.Gln471Glu NC_000010.11:g.87960984C>G NM_000314.8:c.892C>G p.Q298E NM_001304718.2:c.301C>G More...
|
08/04/2023 |
missense variant |
likely benign|uncertain significance |
1 in 200,000 |
AllHighlyPenetrant; B-K MOLE SYNDROME; Bannayan-Riley-Ruvalcaba syndrome; Bannayan-Zonana syndrome; Breast cancer, familial; Cancer predisposition; Carcinoma, squamous cell of head and neck; Cowden syndrome 1; Cutaneous malignant melanoma 1; DYSPLASTIC NEVUS SYNDROME, HEREDITARY; Endometrial carcinoma, somatic; FAMILIAL ATYPICAL MOLE-MALIGNANT MELANOMA SYNDROME; Familial meningioma; Glioma susceptibility 2; Head and neck squamous cell carcinoma; Hereditary Cancer Syndrome; Hereditary neoplastic syndrome; Macrocephaly multiple lipomas and hemangiomata; Macrocephaly pseudopapilledema and multiple hemangiomas; Macrocephaly-autism syndrome; Macrocephaly/autism syndrome; Malignant tumor of prostate; MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1; MELANOMA, MALIGNANT; MELANOMA, MALIGNANT, SOMATIC; Meningioma, familial, susceptibility to; Neoplastic Syndromes, Hereditary; none provided; Prostate cancer; PTEN Hamartomatous Tumour Syndrome; PTEN-related disorders; Riley-Smith syndrome; Ruvalcaba -Myhre-Smith syndrome; Squamous cell carcinoma of the head and neck; Squamous cell carcinoma, head and neck, somatic; THYROID CANCER, NONMEDULLARY, 2; THYROID CANCER, NONMEDULLARY, 2, SUSCEPTIBILITY TO; Thyroid carcinoma, follicular, somatic; Tumor predisposition; VACTERL association with hydrocephalus; VACTERL with hydrocephalus; VACTERL-H |